3SBio Investor Relations Material
Latest events
H2 2024
25 Mar, 2025
H1 2024
21 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from 3SBio Inc
Access all reports
3SBio Inc. is a China-based biotechnology company engaged in the research, development, manufacturing, and commercialization of biopharmaceutical products. The company focuses on therapeutic areas such as oncology, nephrology, autoimmune diseases, and dermatology. Its product portfolio includes monoclonal antibodies, recombinant proteins, and other biologic treatments. The company is headquartered in Shenyang, China, and its shares are listed on the HKEX.
)
)
)